Welcom to our portfolio
| Description | |
| Product Name | Entecavir |
| Synonym | 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one, 2-Amino-9-[(1S,3R,4S)-4-hydroxy-3-hydroxymethyl-2-methylene-cyclopentyl]-3,9-dihydro-purin-6-one, BMS 200475, SQ 34,676 |
| Product Information | |
| Cas Registration No. | 142217-69-4 |
| Chemical Formula | C12H15N5O3 |
| Molecule Weight | 277.28 |
| HS Code | |
| Application | Entecavir
is an antiviral guanine analog that inhibits reverse transcription, DNA
replication and transcription in the viral replication process. Entecavir is
used to treat hepatitis B. Entecavir is used as an effective drug to treat lamivudine-refractory patients with chronic hepatitis B virus (CHB) at a dose of 1 mg daily |
| Characteristics | |
| Quality Specification | |
| Appearance | White to off white Powder |
| Dose Form | Oral Grade |
| Specification | USP |
| Storage / Packing Information | |
| Storage | ≤25℃ |
| Packing Unit | 1G / 100G / 1KG / 10KG |
| Custom Information | |
| GMP | GMP, PIC/S |
| DMF | DMF in CTD |
| Development | Commercialized |